BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28620890)

  • 1. Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome.
    Concolino P; Rizza R; Hackmann K; Minucci A; Scaglione GL; De Bonis M; Costella A; Zuppi C; Schrock E; Capoluongo E
    Mol Diagn Ther; 2017 Oct; 21(5):539-545. PubMed ID: 28620890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome.
    Concolino P; Rizza R; Hackmann K; Paris I; Minucci A; De Paolis E; Scambia G; Zuppi C; Schrock E; Capoluongo E
    Breast Cancer Res Treat; 2017 Jul; 164(2):497-503. PubMed ID: 28488140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.
    Rizza R; Hackmann K; Paris I; Minucci A; De Leo R; Schrock E; Urbani A; Capoluongo E; Gelli G; Concolino P
    Mol Diagn Ther; 2019 Feb; 23(1):121-126. PubMed ID: 30506513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
    Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin.
    Ruiz de Garibay G; Gutiérrez-Enríquez S; Garre P; Bonache S; Romero A; Palomo L; Sánchez de Abajo A; Benítez J; Balmaña J; Pérez-Segura P; Díaz-Rubio E; Díez O; Caldés T; de la Hoya M
    Breast Cancer Res Treat; 2012 May; 133(1):273-83. PubMed ID: 22434521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex Characterization of Germline Large Genomic Rearrangements of the
    Bozsik A; Pócza T; Papp J; Vaszkó T; Butz H; Patócs A; Oláh E
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.
    Fachal L; Blanco A; Santamariña M; Carracedo A; Vega A
    PLoS One; 2014; 9(3):e93306. PubMed ID: 24686251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity reclassification of two BRCA1/BRCA2 exonic duplications after identification of genomic breakpoints and tandem orientation.
    Pinheiro M; Peixoto A; Santos C; Escudeiro C; Bizarro S; Pinto P; Santos R; Pinto C; Guerra J; Silva J; Teixeira MR
    Cancer Genet; 2020 Oct; 248-249():18-24. PubMed ID: 32971473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tandem duplication of BRCA1 exons 1-19 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome.
    Du C; Mark D; Wappenschmidt B; Böckmann B; Pabst B; Chan S; Cao H; Morlot S; Scholz C; Auber B; Rhiem K; Schmutzler R; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res Treat; 2018 Dec; 172(3):561-569. PubMed ID: 30191368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high-throughput sequencing.
    van Luttikhuizen JL; Bublitz J; Schubert S; Schmidt G; Hofmann W; Morlot S; Buurman R; Auber B; Schlegelberger B; Steinemann D
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1045. PubMed ID: 31724318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast Detection of a BRCA2 Large Genomic Duplication by Next Generation Sequencing as a Single Procedure: A Case Report.
    Nunziato M; Starnone F; Lombardo B; Pensabene M; Condello C; Verdesca F; Carlomagno C; De Placido S; Pastore L; Salvatore F; D'Argenio V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.
    Yang C; Arnold AG; Trottier M; Sonoda Y; Abu-Rustum NR; Zivanovic O; Robson ME; Stadler ZK; Walsh MF; Hyman DM; Offit K; Zhang L
    Breast Cancer Res Treat; 2016 Dec; 160(3):447-456. PubMed ID: 27757719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.
    Muller D; Rouleau E; Schultz I; Caputo S; Lefol C; Bièche I; Caron O; Noguès C; Limacher JM; Demange L; Lidereau R; Fricker JP; Abecassis J
    BMC Med Genet; 2011 Sep; 12():121. PubMed ID: 21939546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.
    James PA; Sawyer S; Boyle S; Young MA; Kovalenko S; Doherty R; McKinley J; Alsop K; Beshay V; Harris M; Fox S; Lindeman GJ; Mitchell G
    Fam Cancer; 2015 Jun; 14(2):287-95. PubMed ID: 25678442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.
    Santonocito C; Scapaticci M; Guarino D; Bartolini A; Minucci A; Concolino P; Scambia G; Paris I; Capoluongo E
    Breast; 2017 Dec; 36():74-78. PubMed ID: 29020660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of
    Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
    J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
    Hackmann K; Kuhlee F; Betcheva-Krajcir E; Kahlert AK; Mackenroth L; Klink B; Di Donato N; Tzschach A; Kast K; Wimberger P; Schrock E; Rump A
    Breast Cancer Res Treat; 2016 Oct; 159(3):585-90. PubMed ID: 27581129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.